Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes

Area of Science:

• Nanomedicine
• Bioengineering
• Medical Imaging

Background:

• Cancer is a leading global cause of death, with delayed diagnosis impacting survival rates.
• Immunotherapy has advanced cancer treatment but faces challenges like non-response and side effects.
• Nanotheranostics integrate diagnosis and therapy, offering potential to improve immunotherapy.

Purpose of the Study:

• To review recent advancements in nanotheranostics for cancer immunotherapy.
• To explore how nanomedicine and imaging enhance immunotherapy safety and efficacy.
• To discuss the combined application of tumor imaging and cancer immunotherapy.

Main Methods:

• Review of recent developments in nanomedicine and bioengineering.
• Analysis of theranostic nanoparticle applications in preclinical cancer models.
• Focus on integrating imaging techniques with immunotherapy strategies.

Main Results:

• Nanotheranostics show promise in improving diagnostic accuracy for tumors.
• Preclinical studies indicate enhanced immunotherapeutic potential using nanoparticles.
• Integration of imaging and therapy within a theranostic framework shows positive outcomes.

Conclusions:

• Nanotheranostics represent a promising frontier for overcoming immunotherapy limitations.
• Combining tumor imaging with immunotherapy via nanotheranostics can improve patient outcomes.
• Further research in nanotheranostics holds potential for safer and more effective cancer treatments.